BioMarin Pharmaceuticals BMRN Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's common stock?
- BioMarin Pharmaceuticals (BMRN) reported common stock of 500M in Q1 2026.
- How has BioMarin Pharmaceuticals's common stock changed year-over-year?
- BioMarin Pharmaceuticals's common stock decreased by 0.0% year-over-year, from 500M to 500M.
- What is the long-term trend for BioMarin Pharmaceuticals's common stock?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's common stock has grown at a 387.3% compound annual growth rate (CAGR), from 182K to 500M.
- What does common stock mean?
- The nominal value of the company's issued common shares.
- How do you interpret common stock?
- Changes in this figure usually reflect share issuances or buybacks, impacting the company's capital structure and ownership dilution.
- How does common stock compare across companies?
- Standard equity component; typically stable unless major equity financing or buyback programs occur.